Home > Investor > Financial Highlights > Revenues by country

Revenues by country

Distribution of sales revenues by geographic region 
 %
Europe 32
Bulgaria  66
Other 2

The contribution of sales in Bulgaria to the consolidated sales revenue in the first quarter of 2020 amounted to 66%, increasing by 19% compared to the first quarter of 2019. Sopharma has a 3% share on the Bulgarian pharmaceutical market in terms of value and a 11 % share in terms of sold quantity (units):

  • Novartis: 6.4% (4% in units)
  • Roche: 6.3% (0.3 in units)
  • Actavis: 4.3% (10% in units)
  • GlaxoSmithKlein: 3.9% (2.8% in units)
  • Abbvie: 3.7% (0% in units)
  • Sanofi-Aventis: 2.7% (2% in units)
  • Astra Zeneca: 2.7% (0.4% in units)
  • Pfizer: 3.8% (1% in units)
  • Merck: 3.9% (0.7% in units)